论文部分内容阅读
MaxEPA是一种海鱼油衍生物。这种鱼油富含ω_3多价不饱和脂肪酸,可显著地降低正常的志愿者和正施行血液透析患者的收缩压。其治疗方法是:男女患者各8例,年龄45～74岁(平均54.8岁)。仰卧时血压为200/90～110mmHg。在不加治疗两个月后,随机分配入双盲治疗组。①试验组服MaxEPA16.5g/天;②对照组服外表无法识别的安慰剂。6周后进行交叉替换治疗。治疗初期与6周后还分别测定了纤维
MaxEPA is a marine fish oil derivative. This fish oil is rich in omega-3 polyunsaturated fatty acids and significantly reduces systolic blood pressure in normal volunteers and in hemodialysis patients. The treatment is: male and female patients of 8 cases, aged 45 to 74 years (mean 54.8 years). Supine blood pressure of 200/90 ~ 110mmHg. Two months after no treatment, they were randomly assigned to double-blind treatment. ① test group served MaxEPA16.5g / day; ② control group to take the appearance of unidentifiable placebo. After 6 weeks for cross-replacement therapy. The initial and 6 weeks after the treatment were also measured fiber